
Journal of Affective Disorders, Год журнала: 2023, Номер 344, С. 319 - 324
Опубликована: Окт. 14, 2023
Язык: Английский
Journal of Affective Disorders, Год журнала: 2023, Номер 344, С. 319 - 324
Опубликована: Окт. 14, 2023
Язык: Английский
Journal of Affective Disorders, Год журнала: 2025, Номер unknown
Опубликована: Май 1, 2025
Язык: Английский
Процитировано
0Research Square (Research Square), Год журнала: 2025, Номер unknown
Опубликована: Май 8, 2025
The link between obesity and depression is bidirectional antidepressant efficacy reduced in obese individuals. To probe this mechanism, anthropometric measures (body mass index [BMI] waist circumference [WC]) from 85 participants (n = 56 females, n 29 males) with Major Depressive Disorder (MDD) were acquired. Participants then received simultaneous positron emission tomography (PET)/magnetic resonance imaging (MRI) before after treatment a double-blind randomized trial of escitalopram. Linear mixed models used to examine the association continuous categorical pretreatment amygdala hippocampus volumes metabolism, controlling for covariates. Similar assessed percent change brain volume metabolism treatment, type. Pretreatment, was significantly positively associated (p 0.0160 0.0154, WC BMI, respectively) 0.0221 BMI) volume, but not metabolism. With each additional inch (or lb/in 2 -0.38% -0.26%) treatment-induced volume. In fact, past 37.29 (border increased risk males, substantially females) or 30.63 (obese range), shifts positive (increasing) negative (decreasing). Further, every 1 there 1.03% (amygdala) 0.99% (hippocampus) increase treatment. This multimodal study first suggests that obesity-related factors may alter structure hippocampus, potentially reducing effectiveness MDD.
Язык: Английский
Процитировано
0Nutrients, Год журнала: 2025, Номер 17(10), С. 1607 - 1607
Опубликована: Май 8, 2025
Women exhibit unique vulnerabilities in health, especially regarding mental health and neurodegenerative diseases. Biological, hormonal, metabolic differences contribute to sex-specific risks that remain underrepresented clinical studies. Diseases such as major depressive disorder (MDD) Alzheimer’s disease (AD) are more prevalent women may be influenced by hormonal transitions, particularly during menopause. Chronic low-grade inflammation is emerging a shared mechanism underlying both conditions, this inflammatory state can worsened dietary habits. During menopause, mood sleep disturbances influence behavior, leading enhanced snacking consumption of high-glycemic comfort foods. Such foods, low nutritional value, promote weight gain elevated markers. Their combined (or not) with preexisting Western diet pattern—already linked inflammation—could reinforce systemic involving the gut–brain axis. Moreover, symptoms “per se” could act on well. Peripheral cross blood–brain barrier, sustaining disorders promoting changes. Finally, MDD AD associated conditions obesity diabetes, which occur frequently women. The review highlights how menopause-related changes mood, sleep, heighten susceptibility
Язык: Английский
Процитировано
0Frontiers in Nutrition, Год журнала: 2025, Номер 12
Опубликована: Май 9, 2025
Objective The objective was to evaluate ABSI’s association with depression and explore FBG as a possible mediating factor. Methods Data from 8,748 NHANES participants (2017–2023) were analyzed. Logistic regression analyses assessed ABSI-depression associations, while mediation models tested FBG’s intermediary role. We conducted stratified interaction test assess the impact of gender, age, race, PIR, education, alcohol use, current smoking status, BMI, hypertension history hypercholesterolemia on study outcomes. Results fully adjusted logistic demonstrated significant positive between ABSI (OR = 1.20, 95%CI: 1.00, 1.44, p 0.0497). Stratified showed that this only among some college education or above (P for < 0.05). No interactions found across other subgroups. Mediation revealed partially mediated relationship (15.8%, 0.0001). Conclusion associated depression, potentially through FBG.
Язык: Английский
Процитировано
0Journal of Affective Disorders, Год журнала: 2023, Номер 344, С. 319 - 324
Опубликована: Окт. 14, 2023
Язык: Английский
Процитировано
6